Alan Ezekowitz

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Greg Tourangeau, as attorney-in-fact for Alan Ezekowitz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan Ezekowitz:

Company Role Class Num Shares Value Price $ Report Date Ownership
Septerna, Inc. Director Common Stock 117,420 $813,451 $6.93 07 Mar 2025 Direct
Organon & Co. Director Phantom Stock 62,703 $629,534 $10.04 13 Jun 2025 Direct
Fulcrum Therapeutics, Inc. Director Stock Option (right to buy) 36,000 26 Jun 2025 Direct
Septerna, Inc. Director Stock Option (Right to Buy) 16,623 17 Jun 2025 Direct

Insider Reports Filed by Alan Ezekowitz

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FULC Fulcrum Therapeutics, Inc. 26 Jun 2025 1 $0 4 Director 30 Jun 2025, 16:15
SEPN Septerna, Inc. 17 Jun 2025 1 $0 4 Director 20 Jun 2025, 18:36
OGN Organon & Co. 13 Jun 2025 1 +$240,000 4 Director 16 Jun 2025, 17:21
SEPN Septerna, Inc. 07 Mar 2025 1 +$92,270 4 Director 10 Mar 2025, 16:18
SEPN Septerna, Inc. 04 Mar 2025 3 +$515,934 4 Director 06 Mar 2025, 21:02
SEPN Septerna, Inc. 24 Oct 2024 0 $0 3 Director 24 Oct 2024, 21:28
FULC Fulcrum Therapeutics, Inc. 17 Jun 2024 1 $0 4 Director 18 Jun 2024, 16:20
OGN Organon & Co. 07 Jun 2024 1 +$200,000 4 Director 11 Jun 2024, 15:17
FULC Fulcrum Therapeutics, Inc. 27 Jun 2023 1 $0 4 Director 29 Jun 2023, 16:16
OGN Organon & Co. 09 Jun 2023 1 +$200,005 4 Director 13 Jun 2023, 16:51
FULC Fulcrum Therapeutics, Inc. 27 Jun 2022 2 $0 4 Director 29 Jun 2022, 17:00
OGN Organon & Co. 10 Jun 2022 1 +$199,994 4 Director 14 Jun 2022, 19:32
FULC Fulcrum Therapeutics, Inc. 09 Jun 2021 1 $0 4 Director 11 Jun 2021, 17:10
OGN Organon & Co. 04 Jun 2021 1 +$316,231 4 Director 08 Jun 2021, 20:39
OGN Organon & Co. 02 Jun 2021 0 $0 3 Director 02 Jun 2021, 17:54